Research Use Only: This product is supplied for laboratory research and in-vitro studies. Not for human or veterinary administration.
GLOW BLEND (50mg)
- Triple-Peptide Blend: BPC-157 + TB-500 + GHK-Cu for comprehensive tissue regeneration
- Multi-Phase Coverage: Inflammation, angiogenesis, cell migration, and matrix remodeling
- Research Formulation: 50mg total, ≥98% purity per component, lyophilized powder
- Mechanistic pathway studies
- In vitro receptor profiling
- HPLC verified identity and purity
Ships same-day if ordered before 2PM EST
Research Overview
GLOW Blend is a triple-peptide research formulation combining three extensively studied regenerative compounds: BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 Acetate), and GHK-Cu (Copper Tripeptide-1). This combination enables investigation of synergistic tissue regeneration, wound healing, and extracellular matrix remodeling pathways. The scientific rationale leverages complementary mechanisms across different phases of tissue repair, from initial inflammation control through final matrix organization.
BPC-157, a 15-amino acid gastric peptide, has been the subject of extensive research focusing on nitric oxide system modulation and VEGFR2-mediated angiogenesis. Hsieh et al. (2017) identified VEGFR2 as the primary target for BPC-157's pro-angiogenic effects, while Seiwerth et al. (2018) provided comprehensive comparison with standard angiogenic growth factors across multiple tissue injury models. TB-500, a 43-amino acid thymic peptide, functions as a high-affinity G-actin sequestering protein (Kd ~0.5-0.7 μM) that promotes cell migration and upregulates VEGF expression via Wnt/β-catenin pathways. Recent research by Bock-Marquette et al. (2023) examined TB-4 in cardiac regenerative models, demonstrating anti-aging and tissue repair effects.
GHK-Cu, the copper tripeptide complex, represents a unique regenerative mechanism through copper-dependent enzyme activation. Pickart and Margolina's 2018 genomic analysis revealed GHK-Cu affects over 4,000 human genes, including upregulation of collagen I/III synthesis, elastin production, and antioxidant enzyme induction. The peptide serves as a copper chaperone delivering Cu²⁺ to lysyl oxidase for collagen crosslinking, superoxide dismutase for antioxidant defense, and cytochrome c oxidase for cellular respiration. This multi-component blend provides a research tool for investigating whether combined pathway activation produces synergistic benefits in comprehensive tissue regeneration.
Primary Research Applications
Mechanism of Action
BPC-157 Pathways
Nitric Oxide System and Angiogenesis — BPC-157 activates the Src-Caveolin-1-eNOS pathway, leading to endothelial nitric oxide synthase liberation and NO production for vasodilation and angiogenesis. The peptide upregulates VEGFR2 (vascular endothelial growth factor receptor 2) and promotes receptor internalization, activating Akt-eNOS and ERK1/2 MAPK signaling cascades. Additionally, BPC-157 stimulates the FAK-paxillin pathway, supporting cell migration and adhesion dynamics critical for tissue repair.
TB-500 Pathways
Cytoskeletal Dynamics and Cell Migration — TB-500 functions as a high-affinity G-actin sequestering protein, binding actin monomers with 1:1 stoichiometry (Kd ~0.5-0.7 μM) to prevent uncontrolled polymerization. This enables rapid cytoskeletal remodeling essential for cell motility and migration. TB-500 directly upregulates VEGF expression via the Wnt/β-catenin/Lef-1 pathway and increases MMP-2 expression, promoting endothelial cell migration and neovascularization. Recent research demonstrates anti-fibrotic activity through Hedgehog pathway modulation.
GHK-Cu Pathways
Copper-Dependent Enzyme Activation — GHK-Cu serves as a copper chaperone delivering Cu²⁺ to multiple enzymes: lysyl oxidase for collagen crosslinking, superoxide dismutase and catalase for antioxidant defense, and cytochrome c oxidase for cellular respiration. The peptide stimulates collagen I and III synthesis through gene expression modulation, upregulates elastin production, and regulates matrix metalloproteinases (MMP-1, MMP-2) for controlled matrix remodeling. Pickart's genomic analysis revealed GHK-Cu affects over 4,000 human genes, including TGF-β signaling pathways and antioxidant gene expression.
Synergistic Integration
Multi-Phase Tissue Repair Coverage — The three peptides provide complementary coverage across all wound healing phases. During inflammation, BPC-157 provides cytoprotection while all three components modulate inflammatory signaling. In the migration phase, TB-500's actin sequestration and BPC-157's FAK-paxillin activation enable cell chemotaxis, with GHK-Cu providing additional chemotactic signals. For angiogenesis, BPC-157 activates VEGFR2 receptors, TB-500 upregulates VEGF ligand, and GHK-Cu supports vessel maturation. In the final remodeling phase, GHK-Cu drives collagen synthesis and MMP regulation, TB-500 prevents excessive fibrosis, and BPC-157 maintains vascular support for the regenerating tissue.
“Mechanistic summaries on this page are provided for laboratory reference and should be interpreted within controlled experimental settings only.”
Preclinical Research Summary
BPC-157's regenerative effects are documented across multiple tissue types. Hsieh et al. (2017) in the Journal of Molecular Medicine identified VEGFR2 as the primary molecular target, demonstrating that BPC-157 promotes receptor internalization and downstream Akt-eNOS signaling for angiogenesis. Seiwerth et al. (2018) provided comprehensive comparison of BPC-157 with standard angiogenic growth factors in Current Pharmaceutical Design, showing comparable or superior effects in various tissue injury models. The peptide's unique ability to modulate both NO excess and deficiency states suggests bidirectional regulatory mechanisms.
TB-500's cellular effects are well-characterized in migration and angiogenesis research. The peptide's high-affinity G-actin binding (Kd ~0.5-0.7 μM) enables rapid cytoskeletal remodeling essential for cell motility. Bock-Marquette et al. (2023) in International Immunopharmacology demonstrated thymosin beta-4's regenerative effects in cardiac models, showing anti-aging benefits and tissue repair promotion. Recent 2023 research in the journal Cells revealed that TB-4 deletion ameliorated liver fibrosis through Hedgehog pathway modulation, highlighting its role in preventing excessive fibrotic responses.
GHK-Cu's regenerative mechanisms are supported by extensive genomic and biochemical research. Pickart and Margolina's landmark 2018 study in International Journal of Molecular Sciences analyzed GHK-Cu effects on over 4,000 human genes, demonstrating upregulation of collagen I/III, elastin, and antioxidant enzymes. Kang et al. (2009) in Journal of Investigative Dermatology confirmed GHK-Cu stimulates collagen synthesis and decorin expression in human dermal fibroblasts. The peptide's copper chaperone function delivers Cu²⁺ to lysyl oxidase for collagen crosslinking, providing structural integrity to newly formed tissue. While each component has independent research supporting regenerative effects, controlled studies examining this specific triple-combination blend remain limited, representing an area for future investigation.
Academic References
- Hsieh MJ et al. (2017). BPC157 enhances the growth hormone receptor expression in tendon fibroblasts. Journal of Molecular Medicine.
- Seiwerth S et al. (2018). BPC 157 and standard angiogenic growth factors - Gastrointestinal tract healing, lessons learned and novel therapeutic implications. Current Pharmaceutical Design.
- Bock-Marquette I et al. (2023). Thymosin beta-4: A multi-faceted tissue repair stimulating protein in regeneration and anti-aging that requires further clinical studies. International Immunopharmacology.
- Zhang L et al. (2023). Thymosin-β4 Deletion Ameliorates Liver Fibrosis via Suppression of Hepatic Stellate Cell. Cells.
- Pickart L, Margolina A (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences.
- Pickart L et al. (2012). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. International Journal of Molecular Sciences.
- Kang YA et al. (2009). Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Journal of Investigative Dermatology.
- Singer AJ, Clark RA (1999). Cutaneous Wound Healing. New England Journal of Medicine.
This product is intended exclusively for in vitro laboratory research by qualified professionals. Not for human consumption. Not approved by the FDA.